View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 10/11: (UA) (TWTR) (TSO) Upgraded; (HBAN) (MSCI) (NBR) Downgraded
-
Roth Capital Starts GrubHub Inc. (GRUB) at Neutral
-
Roth Capital Starts American Superconductor (AMSC) at Buy
-
Roth Capital Affirms Ballard Power (BLDP) at 'Buy'; Says FY17 Fuel Cell Outlook is 'Robust'
-
Roth Says Hydrogenics (HYGS) Remains Key Player in PEM Electrolysis Segment; Affirms at 'Buy'
-
Ocean Power Technologies (OPTT) Announces 2.5M Share Common Stock Offering
-
Ocean Power Technologies, Inc. Launches Common Stock Offering
-
Superior Drilling Products, Inc. Announces Closing of Follow-on Equity Offering
-
Roth Capital Cuts PT on Acuity Brands (AYI) to $250 Following Q4 Numbers; Still Sees Tough FY17
-
CallidusCloud Announces Full Exercise of Underwriters' Option to Purchase Additional Shares of Common Stock
-
Roth Capital Downgrades IRadimed Corp (IRMD) to Neutral
-
Roth Capital Starts Vertex Energy (VTNR) at Neutral
-
Roth Capital Starts Vertex Energy (VTNR) at Neutral
-
Actinium Announces Closing of Public Offering of Common Stock
-
Roth Capital Raises Price Target as Green Plains (GPRE) Completes SCI Ingredients Acquisition
-
Roth Capital Upgrades MAG Silver Corp (MAG) to Buy
-
Streetinsider.com's Hot Lunchtime Reads 10/3: (REGN) (AAPL) (NGVT) (CTSH)
-
Roth Capital 'Impressed' by Latest Dupixent Data; Affirms Regeneron (REGN) at 'Buy'
-
UPDATE: Roth Capital Starts Fortress Biotech (FBIO) at Buy, PT $9
-
UPDATE: Roth Capital Starts Sorrento Therapeutics (SRNE) at Buy
-
Roth Capital Starts Alarm.com (ALRM) at Buy
-
Roth Capital Affirms Regeneron (REGN) at 'Buy' Following Eylea Phase 2 Data in Wet-AMD
-
Delcath Systems (DCTH) Prices ~$1.28M Common Stock, Warrants Offering
-
Delcath Prices Underwritten Public Offering of Common Stock and Warrants
-
Superior Drilling Products (SDPI) Prices 5M Share Offering at $1/Share
-
Superior Drilling Products, Inc. Announces Pricing of Follow-on Equity Offering
-
Delcath Systems (DCTH) to Offer Common Stock and Warrants
-
Delcath Announces Proposed Public Offering of Common Stock and Warrants
-
Notable Analyst Rating Changes 9/29: (OZM) (EBAY) (EMES) Upgraded; (AAPL) (FIT) (MANT) Downgraded
-
Pre-Open Stock Movers 09/29: (AEGR) (ARWR) (EBAY) Higher; (ITCI) (ADHD) (FIT) Lower (more...)
-
Actinium Pharma (ATNM) Prices 8M Common Stock Offering at $1.25/Share
-
Actinium Announces Pricing of Public Offering of Common Stock
-
Roth Capital Starts CEVA Inc. (CEVA) at Buy
-
After-Hours Stock Movers 09/28: (AEGR) (PIR) (GSAT) Higher; (ITCI) (ATNM) (PRGS) Lower (more...)
-
Roth Capital Starts Ambarella (AMBA) at Buy
-
Roth Capital Starts Magnachip Semiconductor (MX) at Buy
-
Roth Capital Starts Silicon Motion Technology (SIMO) at Buy
-
Roth Capital Starts Silicon Labs (SLAB) at Buy
-
Roth Capital Starts Integrated Device Technology (IDTI) at Buy
-
Roth Capital Starts Himax Technologies (HIMX) at Buy
-
Roth Capital Downgrades Galectin Therapeutics (GALT) to Sell
-
Roth Capital Reaffirms Actinium Pharma (ATNM) at 'Buy'; Says Starting Actimab-A Phase 2 is 'Important Step'
-
Roth Capital Affirms Pieris Pharma (PIRS) at 'Buy' Following Positive PRS-343 Data
-
Roth Capital Trims PT on Ligand Pharma (LGND) to $150 Amid New Kyprolis Data (AMGN)
-
Roth Capital Keeps Ballard Power (BLDP) at 'Buy' Amid New Audi Orders
-
Streetinsider.com's Hot Lunchtime Reads 9/26: (REGN) (ONTX) (LITE) (SFL)
-
Roth Capital Reaffirms Regeneron (REGN) at 'Buy'; Dupilumab BLA in AD Key Next Step in Development
-
Roth Capital Downgrades Digital Turbine (APPS) to Neutral
-
Roth Capital Keeps BioLineRx (BLRX) at 'Buy' Amid New in-Licensing Agreement
-
Roth Capital Starts Mindbody (MB) at Buy

